TFL vs MOSES Holmium Laser in the En-bloc Resection of Bladder Tumors
Recruiting now NCT06373419
Run by Thunder Bay Regional Health Research Institute · for 18 and older · All sexes
What this study is about
The goal of this randomized clinical trial is to determine if there is difference in pathological and clinical outcomes between MOSES and TFL in the transurethral laser enucleation of bladder tumors. The main question it aims to answer is: Is there a difference in pathological and clinical outcomes between MOSES Holmium and Thulium Fiber Laser (TFL) in the transurethral laser enucleation of bladder tumors? Participants will randomized to either TFL of MOSES arm for their bladder resection procedure.
Who can join (things the study team will check)
✅ You may be able to join if…
- Over 18 years of age at the time of enrollment.
- Patients presented with visual criteria suggesting bladder tumor by outpatient cystoscopy will be legible for inclusion.
🚫 You may not be able to join if…
- Tumors deemed not eligible for laser resection as determined by the Urologist e.g. obvious muscle-invasive or metastatic at presentation
- Synchronous either urethral tumors or upper urinary tract tumor
- History of Carcinoma in situ
- Contracted bladder
Where this trial is running
- Thunder Bay Regional Health Sciences Centre, Thunder Bay, Ontario, Canada
Who to contact
Rabail Siddiqui · (807) 684-6000 · rabail.siddiqui@tbh.net
It's completely normal to call and ask questions before deciding anything. Mention the study ID: NCT06373419.
Verify everything on the official ClinicalTrials.gov record. Page updated July 2026.